Predicting Mortality in Patients Developing Recurrent Hepatocellular Carcinoma After Liver Transplantation: Impact of Treatment Modality and Recurrence Characteristics.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To evaluate predictors of mortality and impact of treatment in patients developing recurrent hepatocellular carcinoma (HCC) following liver transplantation (LT).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Ann. Surg.

Title: Annals of surgery

Publisher: Ovid Technologies (Wolters Kluwer Health)

ISSN (Electronic): 1528-1140

ISSN (Print): 0003-4932

Publication date (Electronic): July 2017

Volume: 266

Issue: 1

Affiliations

[1 ] *Department of Surgery, Dumont-UCLA Transplant and Liver Cancer Centers, Los Angeles, CA †Section of Transplantation, Department of Surgery, University of Chicago, Chicago, IL ‡J.C. Walter Jr. Center for Transplantation, Department of Surgery, Houston Methodist Hospital, Houston, TX §Department of Biomathematics, David Geffen School of Medicine at University of California, Los Angeles, CA.

Article

DOI: 10.1097/SLA.0000000000001894

PubMed ID: 27433914

SO-VID: 7e15e47c-f856-4b66-8f5f-6846d1c0561a

History

Data availability:

Comments

Comment on this article

scite_

Cited by 64

See all cited by